Signal transduction molecules within the two-component family represent a conserved adaptation for the control of genes involved in pathogenesis. The Bordetella virulence control locus, bvgAS, activates and represses gene expression in response to environmental signals. While infection requires virulence gene activation, the role of gene repression during infection is not understood. By altering regulatory genes and reversing regulatory connections, we found evidence that the BvgAS-repressed genes responsible for motility are neither required nor expressed during colonization of the host. Expression of this Bvg-phase-specific phenotype in the Bvg ÷ growth phase resulted in a defect in tracheal colonization. Therefore, BvgAS promotes virulence both by activating genes required for colonization and by repressing genes that inhibit the development of infection.
Introduction
Host-microbe interactions exert selection for organisms that can acquire information and ~se it to influence the outcome of infection. Two-component signal transduction systems are thought to represent a primary mechanism supplying bacterial pathogens with information about the host environment (reviewed by Miller et al., 1989; Parkinson, 1993) . A sensor component, typically found in the plasma membrane, transfers a phosphoryl group to a regulator component that effects a change in bacterial behavior or gene expression (reviewed by Stock et al., 1989; Parkinson and Kofoid, 1992) . Although a number of such systems have been implicated in bacterial virulence, their roles in facilitating interactions with the host are not well understood. The bacterial genus Bordetella provides a paradigm for the mechanisms used by microbial pathogens to interact with and respond to the host environment. Bordetella are gram-negative bacteria that infect the respiratory tracts of a variety of animals, producing a spectrum of manifestations. Bordetella pertussis causes paroxysmal coughing in humans, Bordetella avium causes coryza in turkeys, and Bordetella bronchiseptica induces atrophic rhinitis in pigs and persistent, asymptomatic infections in rabbits. Studies of Bordetella pathogenesis implicate signal transduction by the prokaryotic cell in the production and maintenance of infection. All of the currently known genes associated with Bordetella pathogenesis are coordinately regulated by a single locus, bvgAS, also designated vir , whose biochemical properties and predicted amino acid sequence place it within the two-component family of signal-transducing proteins (Arico et al., 1989; Uhl and Miller, 1994) .
Consistent with the two-component paradigm, the bvgAS locus encodes proteins that transmit extracellular signals to the cellular transcription machinery, causing changes in gene expression . This signal transduction event can be induced in the laboratory by altered growth conditions, resulting in a morphogenic transition between two distinct phenotypic phases ( Figure  1A ). One phase (Bvg ÷) requires BvgAS and is characterized by the induction of vir-activated genes (vags), a class of loci including genes encoding the adhesins and toxins that comprise most of the known virulence factors (Weiss et al., 1983) . The other phase (Bvg-) is defined by the absence of vag-encoded factors and the expression of a class of genes called vir-repressed genes (vrgs) . The vrgs include genes required for motility in B. bronchiseptica (Akerley and Miller, 1993) and genes required for the production of a number of outer membrane proteins in B. pertussis (Beattie et al., 1990) . The Bvg-phase occurs when bvg is deleted or when BvgAS activity is suppressed
by specific yet diverse experimental conditions, including the presence of sulfate anion, nicotinic acid, or reduced temperature (25°C versus 37°C). The signals that modulate BvgAS activity in nature have not been identified, and the role of the BvgAS-mediated response to signals is not known. It is tempting to speculate that BvgAS controls gene expression patterns in response to signals present in the host to optimize the development of a successful infection.
Comparison of the bvgAS genes of B. pertussis and B. bronchiseptica reveals 96% identity in their predicted amino acid sequences (Arico et al., 1991) . B. bronchiseptica expresses vags similar to each of the known virulence genes of B. pertussis, with the exception of the pertussis toxin gene, ptx. These species are highly related at the DNA level and have been classified as subspecies on the basis of 23S ribosomal RNA gene sequences (M~ller and Hildebrandt, 1993) . Despite these similarities, the two species infect different hosts, potentially as a result of differences in their respective BvgAS regulons. The difference in host tropism can be exploited experimentally, since B. bronchiseptica infects a variety of laboratory animals, permitting studies of the natural infection process. This level of resolution is not available in studies of B. pertussis, for which humans represent the only natural host. Understanding the complete set of traits that allow a pathogen to thrive requires an experimental system in which all of these features are effective.
While pathogenesis clearly requires vags, the importance of vrg expression remains enigmatic. The production of flagella comprises a distinctive phenotype indicative of Bvg-phase gene expression. The link between the regulation of motility and virulence factors in B. bronchi- (hatched box) and, by a mechanism involving the BvgS receiver domain (solid box), transfers a phosphoryl group to the receiver domain of BvgA (Uhl and Miller, 1994) . Phosphorylated BvgA controls transcription via a regulator domain with DNA-binding activity (oval) (Boucher et al., 1994) . BvgAS induces expression of factors implicated in adherence (spikes) such as FHA, pill, and pertactin and toxins such as pertussis toxin, adenylate cyclase toxin, and dermonecrotic toxin (dots). These factors, with the exception of pertussis toxin, are expressed in both B. pertussis and B. bronchiseptica. Inactivation of BvgA$ in response to signals (termed phenotypic modulation) results in the Bvg growth phase. Bvg-phase B. bronchiseptica produce peritrichous flagella, while B. pertussis produces vrg-6 and several outer membrane proteins.
(B) Motility in B. bronchiseptica is compared with that of the E. coil flagellar regulon (described in the text). BvgAS negatively controls motility and the transcription of two operons required for flagellum production, frlAB and flaA. flaA encodes flagellin, while frlAB encodes an activator of flagellar genes that efficiently complements mutations in the flhDC locus of E. coll. The transcriptional start site of flaA in B. bronchiseptica maps near a consensus recognition sequence found in aF-dependent promoters (matches to consensus are in bold type), and expression of a flaA-lacZfusion introduced into the E. coil chromosome requires GF, suggesting the presence of a iliA analog (circled) in Bordetella. The DNA region 5' of the flhD protein-coding region contains a possible CRP-cAMP-binding site (hatched box). This consensus is not found near the transcriptional start site of frl. A DNA sequence (TAGAAA-nl 6-TAAA'I-[') that resembles the consensus recognition site forthe E. coli major sigma factor a TM is found 5 bp upstream of the transcriptional start site of frl. It is not known whether these flagellar control factors regulate genes other than those involved in the production of motility.
septica suggests that motility control plays a role in pathsgenesis. To address the functional significance of vrg expression and negative control by BvgAS, we investigated flagellar regulation. Comparisons with the flagellar hierarchy of Escherichia coil proved useful in analyzing the flagellar regulon of B. bronchiseptica. FlageUar synthesis proceeds as a cascade of transcriptional control events leading to the ordered expression and assembly of structural proteins that comprise the flagellar organelle (reviewed by Macnab, 1992) . In E. coil, glucose starvation leads to increased production of cAMP, which functions as a coactivator with catabolite repression protein (CRP) to promote expression of the flhDC locus (Silverman and Simon, 1977) . flhD and flhC are early genes of the flagellar hierarchy that encode products required for transcription of middle and late genes (Komeda, 1982) . A B. bronchiseptica locus, frl (for flagellar-regulatory locus), complements flhDC mutations in E. coil (Akerley and Miller, 1993) . Middle genes include iliA, which encodes an alternative sigma factor, c F, required for transcription of late gene promoters, including the promoter for f//C encoding flagellin. The Bordetella flaA gene encodes a flagellin protein with 61% amino acid identity to that of E. coil and contains the E. coil ~F consensus near its transcriptional start site. In addition, flaA requires iliA for heterologous expression in E. coil (Akerley and Miller, 1993) . These findings suggested a model for a BvgAS-regulated transcriptional cascade controlling the motility phenotype in B. bronchiseptica (Figure 1 B) . This report describes an analysis of BvgAS-mediated regulation of motility and the modification of this genetic circuitry to test the role of negative control by BvgAS in the context of the natural environment of Bordetella within a host. The results indicate that BvgAS negatively controls a regulatory locus, frlAB, that is required for the production of flagellar organelles. We reversed the expression pattern of frl by fusing the operon to a BvgAS-activated promoter. This genetic alteration induced motility in the Bvg ÷ growth phase, in which motility is not normally produced. Ectopic expression of frl during the development of a natural respiratory infection reduced colonization by B. bronchiseptica, demonstrating a requirement for both positive and negative regulation by BvgAS during colonization. We propose that one function of signal transduction by virulence control systems consists of preventing the expression of bacterial phenotypes that would otherwise attenuate the virulence of the infecting organism.
Results
The Link between Motility and the Virulence Control System Initial comparisons between the flagellar genes of B. bronchiseptica and E. coil indicated that the frl locus may encode a flhDC analog. Transcription of all flagellar genes in E. coil that have been tested requires flhDC. Therefore, it seemed likely that BvgAS could control motility by exerting negative control at the frl promoter. This hypothesis was investigated by primer extension analysis of B. bronchiseptica RNA (Figure 2) . Transcription from the frl promoter was compared with that of the autoregulated bvg promoters (Pl~vg and P2bvg). Expression of Plbv.q requires active BvgAS, while P2~vg is expressed only when BvgAS is inactive (Roy et al., 1990; Scarlato et al., 1990 by this assay were tested for frl expression. Transcription from the frl promoter was detected when BvgAS was inactivated by the addition of nicotinic acid to the growth medium or by deletion ofbvgAS (Figure 2 , lanes 6 and 7). Transcription of frl was reduced nearly to background levels in the wild-type strain grown under conditions that allow BvgAS activity ( Figure 2 , lane 5). A mutant that is locked in the Bvg + growth phase by a constitutive mutation in bvgS (bvgS-C3), which renders the system insensitive to modulation by environmental signals , failed to express frl RNA in the presence of nicotinic acid ( Figure  2 , lane 8). These results indicated that BvgAS negatively regulates frl expression at the level of transcription. The role of frl in flagellar synthesis was investigated by constructing a deletion encompassing frlA and frlB (see below) in the B. bronchiseptica genome. This mutation abrogated motility (data not shown) and the production of flagellin (see Figure 3B ). Introduction of an episomal copy of the frl locus containing the minimal open reading frames of frlA and frlB restored motility to the frlAB deletion strain (data not shown). Therefore, frlAB is required for motility and the production of flagellin in B. bronchiseptica.
DNA sequence analysis indicated that the frl locus contains two adjacent open reading frames, frlA and frlB. The predicted amino acid sequences of FrlA and FrlB are 44.6% and 53.7% identical to those of FIhD and FIhC (Bartlett et al., 1988) , respectively. A plasmid containing the minimal frlAB open reading frames complemented E. coli flhD and flhC mutations (data not shown), indicating that frlAB encodes functional homologs of the flhDC gene products. Liu and Matsumara (1994) have provided evidence that complexes of FIhD and FIhC activate c~ 7°-dependent transcription of flagellar genes by RNA polymerase. Since frlAB can functionally substitute for flhDC, it too may encode a transcriptional activator comprised of two proteins. The putative promoter region of frl had no marked similarities to that of flhDC (data not shown). The frl promoter contained a close match to the c~ 7° consensus near the transcriptional start site (see legend to Figure 1 ), suggesting that frlA may be transcribed constitutively in the absence of BvgAS-mediated repression.
Reversal of the Transcriptional Control Pattern of frl Reverses the Expression Pattern of the Motility Phenotype
Characterization of the frl locus and comparisons with the E. coli flagellar hierarchy indicated that frl may represent a master regulator of motility in B. bronchiseptica. If this hypothesis is true, then the observed transcriptional control of frl by BvgAS would provide an efficient mechanism for regulating the production of the entire motility apparatus. This model predicts that altering the transcription of frlwill supplant negative control over flagellar morphogenesis, leading to the production of flagella whenever the frl genes are transcribed. To test this hypothesis, we determined whether expression of frl from a BvgAS-activated promoter would place motility under positive control by BvgAS. This strategy required an exogenous BvgAS-activated promoter that could function as a cassette when removed from its native site. Analysis of the fhaB promoter from B. pertussis identified cis-acting DNA sequences required for BvgAS-mediated activation of fhaB transcription (Roy and Falkow, 1991) . Speculating that the analogous B. bronchiseptica sequences might be sufficient for promoter function, we used a 198 bp fragment containing 5' sequences of fhaB to drive frl expression ( Figure 3A ). The frl promoter was disrupted by the introduction of the 198 bp fhaB promoter sequence between the -10 and -35 regions upstream of the transcriptional start site of frl to reduce the likelihood of interference by the native promoter. Control by BvgAS was examined at the level of motility production, flagellar assembly, and flagellin expression in B. bronchiseptica containing this frl-reversed mutation (frf). Expression of frl from the fhaB promoter in the frl r strain REV1 resulted in flagellar morphogenesis in the Bvg + growth phase, a phenotypic state in which wild.type organisms do not express flagella (Figure 4) . Inactivation of BvgAS prevented the induction of flagellar synthesis in REVl. The same regulatory pattern was observed at the level of flagellin synthesis (see Figure 3B ) and production of the motility phenotype (data not shown). These results indicate that BvgAS negatively controls motility by inhibiting transcription from the frl promoter. In addition, this experiment resulted in the construction of a mutant strain in which all vrg loci required for motility are coexpressed with the vag loci, reversing the normal pattern of BvgASmediated control of flagellar synthesis. The interaction between this ectopic expression mutant and the host was then investigated.
The Immune Response to Flagellin Provides a Reporter for BvgAS-Mediated Phase Switching In Vivo
To examine the role of BvgAS in a biologically relevant context, we developed a rat model of infection with B. bronchiseptica. I ntranasal inoculation with a very low dose of bacteria resulted in colonization (ID~o, <20 CFU [colonyforming units]), suggesting that B. bronchiseptica is highly adapted to the rat respiratory tract. The kinetics of colonization with wild-type B. bronchiseptica are shown in Figure  6 . The infection began in the nasal cavity, consistently reached the trachea, and sporadically involved the lungs. Sneezing was observed in most infected rats at approximately day 5 postinoculation.
If BvgAS mediates a morphogenic transition in response to signals present in the host, then the immune system will recognize antigenic proteins specific to both growth phases. Such antigenic molecules can serve as indicators of bacterial gene expression during colonization. Serum from rats infected with wild-type B. bronchiseptica detected multiple antigens on immunoblots containing whole-cell lysates of Bvg ÷ phase cultures of B. bronchiseptica ( Figure  5A , lanes 5 and 7). The majority of these antigens are specific to the Bvg ÷ phase and are not found in Bvg-phase cultures ( Figure 5A , lanes 6 and 8). In enzyme-linked immunosorbent assays (ELISAs), these sera also reacted with purified preparations of filamentous hemagglutinin (FHA) protein, a Bvg + phase factor ( Figure 5A ). These sera did not react, however, with Bvg-phase-specific bands ( Figure 5A , lanes 6 and 8) or with purified flagellin (Figure (Cotter and Miller, 1994) . These observations indicate that BvgAS-activated genes are expressed during infection, while an immune response to Bvg-phase-specific proteins is not detected by the methods used.
Failure to detect a serum antibody response to proteins specific to the Bvg-phase suggests that genes that are negatively controlled by BvgAS are not expressed during colonization. Alternatively, the lack of a response to Bvgphase-specific factors could result from low immunogenicity of these proteins. The frl" mutant REV1 was used to distinguish between these hypotheses. Flagellar production in REV1 is dependent on the BvgAS-activated fhaB promoter, whose expression in vivo has been demonstrated by detection of antibodies to FHA during Bordetella infections. Therefore, REV1 is predicted to express flagella during infection. Serum from REVl-infected rats reacted strongly with both flagellin protein on Western blots ( Figure 5A ; compare lanes 12 and 20) and intact flagellar organelles in ELISAs ( Figure 5B ). The immunoblot shown in Figure 5A is representative of additional immunoblots obtained with serum from five animals in each group. The 40 kDa antigen corresponding to flagellin was detected only with serum from frF-infected rats. Additional Bvgphase-specific antigens were not detected. The response to 13vgAS-induced antigens was similar in all infected rats. Reactivity to a 34 kDa BvgAS-induced band ( Figure 5A , lanes 5, 7, and 9) was observed in serum from four of the rats but did not correlate with the infecting strain, suggesting some heterogeneity in the response to this antigen among individual animals. Antibodies, present only in frlrinfected rat serum, uniformly bound to intact flagellar filaments, as indicated by immunoelectron microscopy (data not shown), demonstrating that the response observed in ELISAs was not directed to a small proportion of denatured epitopes. These results indicate that flagellin is readily detected by the rat immune response when it is expressed during colonization. The lack of response to flagellin in rats infected with wild-type Bordetelia supports the conclusion that flagellin is either not expressed during colonization or that its expression pattern is limited in duration or magnitude.
Ectopic Flagellar Gene Expression Reduces Tracheal Colonization by Bordetella
Lack of detection of vrg expression during infection does not preclude the possibility that these genes may play a role in pathogenesis. Specific mutations in the regulatory pathways controlling vrg loci provide an additional method to address this question. A B. bronchiseptica mutant containing a constitutively active BvgS protein, encoded by the bvgS-C3 allele, did not significantly differ from the parental strain in its ability to colonize rat tracheas, while deletion of bvgS prevented colonization (Figure 6 ). The antibody response, colonization levels, and respiratory tract histology in animals infected with the bvgS-C3 strain versus the parental strain were also indistinguishable from each other in a rabbit model (Cotter and Miller, 1994) .
Since the bvgS-C3 mutant fails to express vrg loci and constitutively expresses vag loci under all conditions tested, the expression of genes that are repressed by BvgAS appears to be inessential for colonization after intranasal inoculation. The caveat remains, however, that conditions unique to growth within a mammalian host may modulate the protein product of the bvgS-C3 allele, in this case, the in vivo expression pattern of vrg loci in the bvgS-C3 strain may resemble that of the wild-type strain The number of CFU recovered in 1 cm of trachea. Rats were inoculated with 1 x 104 CFU ofthe strains indicated, with the exception of the AbvgAS strain, which was inoculated at 6.5 x 10 s CFU. The strains used were as follows: RB50, wt; RB53, bvgS-C3; RBA2, Afrl; REV1, frlr; and RB54, AbvgS. The differences between the frl' and either the wild-type or the frl deletion strain were statistically significant both at day 15 (p < .01 and p < .025, respectively) and at day 26 (p < .005 and p < .025, respectively) (two-tailed t test)• The bvgS deletion strain (AbvgS) was unable to colonize rats in any anatomical site. There were no significant differences in the numbers of CFUs isolated from the wild-type strain and either the frl deletion strain or the bvgS-C3 strain at any time point. At day 15, colonies isolated from two of the frlr-infected rats included nonmotile variants. One rat was colonized with at least 99% nonmotile variants in the trachea (crossed diamond) and 50% nonmotile variants in the nares (asterisk)• This rat was not included in the statistical analysis but probably contained fewer than 102 frl r CFU in the trachea. The second rat was colonized with 3% nonmotile variants in the nares, while no B. bronchiseptica were recovered from its trachea. LLD, lower limit of detection.
(Bottom) The number of animals in which B. bronchiseptica could be detected in the designated anatomical site.
despite the signal insensitivity conferred by bvgS-C3 in vitro. To address directly the question of whether a BvgAS-repressed phenotype is required for colonization, we tested mutant RBA2, containing a deletion in frlAB, in the rat model. No significant difference was detected in the number of CFU recovered from the respiratory tracts of rats infected with the frl knockout strain versus the number from the parental strain, RB50. Productive infection was not the result of reversion of the frl mutation, as bacteria recovered from RBA2-infected rats remained nonmotile. Similar results were obtained with strain RBA6, in which a recombinant I~romoter was placed upstream of the frlAB deletion (see below; Figure 7 ). Together, these data strongly support a model in which BvgAS-activated genes mediate colonization without an observable requirement for BvgAS-repressed genes. This model invokes the possibility that the role of negative control by BvgAS is to prevent the expression of genes that inhibit virulence. To address this question, the frl r mutant (REV1) was compared with wild-type and AfrlAB strains for the ability to colonize rats ( Figure 6 ). All three strains colonized the nasal cavities of infected animals at day 15 and day 26 postinoculation. Tracheal colonization, however, was significantly reduced in the REVl-infected Figure 7 . Genetics of the Persistence Defect Conferred by the frl r Mutation (A) Mutations were introduced into the frl' strain to investigate the phenotype of defective tracheal colonization. It is possible that the frl' phenotype results from expression of potential genes unrelated to motility that are cotranscribed with or activated by frl. If the defect requires ectopic production of,flagella, however, then deletion of the flaA gene is predicted to restore persistence of the frl" strain in the trachea. (B) Respiratory tract colonization by wild-type (RB50), frl r (REVl), frlrAflaA (RBA5), and Afrl' (RBA6). The top shows CFUs isolated from 1 cm of trachea. Differences between the frl r strain and all other strains were statistically significant (p < .005; two-tailed t test). No statistically significant differences were detected among the wild-type, frlrAfrl, and frlrAflaA strains. The bottom panel indicates the number of rats with bacteria at the designated sites in the respiratory tract. In 3 of 5 rats infected with the frl' strain, nonmotile variants were detected in the nares at frequencies of approximately 18o/0, 210/0, and 50/0 (asterisk) (n = 100 colonies tested per rat). LLD, lower limit of detection.
rats as compared with the controls at both timepoints. No CFU were detected in the tracheas of REVl-infected rats at day 26, while the wild-type strain persisted in the trachea to at least day 50. When B. bronchiseptica colonies isolated from REVl-infected rats were screened for motility, nonmotile mutants were detected in populations isolated from 2 of the 5 rats sacrificed at day 15 in one experiment ( Figure 6 ) and 3 of the 5 rats sacrificed at day 26 in a second experiment ( Figure 7B ). These variants were nonmotile under Bvg ÷ and Bvg-conditions, indicating that they did not represent revertants of REVl to wild-type. Experiments with REVl-infected rabbits (data not shown) also yielded nonmotile variants in 2 of 4 infected animals. Both REVl grown in vitro and RB50 grown in animals or on plates failed to give rise to nonmotile mutants in a sample of 1000 colonies tested per strain. The in vivo selection of nonmotile mutants in the frF background and reduced colonization by REV1 indicate a requirement for negative control of frl by BvgAS during respiratory tract infection by B. bronchiseptica.
Several mechanisms could lead to the observed survival defect of REVl ( Figure 7A ). It is possible that the frloperon contains loci downstream of frlAB that are cotranscribed with these genes and could potentially cause the Frl r phenotype during infection. Alternatively, the in vivo defect of the frl' mutant may result from expression of frlAB-regu~ated loci that include motility genes and, potentially, genes that are not involved in motility. If the defective colo-nization pattern specifically requires ectopic flagellar morphogenesis, then disruption of a late gene in the flagellar control pathway should restore wild-type colonization levels to the frl ~ strain. An in-frame deletion was therefore introduced into the flaA gene of the frf mutant. This frl~AflaA strain was tested in the r~t model to assess the basis of the persistence defect. The frlr/lflaA mutant exhibited wild-type colonization levels, indicating that ,JflaA is epistatic to frl' ( Figure 7B ). As predicted, disruption of frlAB also abrogated the in vivo defect conferred by the frl r mutation. These results indicate that potential frl-regulated or cotranscribed genes that are independent of the motility phenotype are not responsible for the defect induced by ectopic frl expression. Furthermore, the evidence strongly supports the hypothesis that inappropriate expression of the flagellar regulon itself disrupts development of the infection.
Discussion
The diverse environments inhabited by bacteria provide a wide range of settings in which a signal transduction event may be biologically relevant. To maximize the opportunity to detect significant aspects of BvgAS-mediated signal transduction, we chose a model that is expected to duplicate closely the natural events in the life cycle of a respiratory pathogen. Intranasal inoculation of rats with B. bronchiseptica at doses lower than 20 CFU results in infection. This infection persists for at least 50 days, producing mild signs of respiratory disease in the form of sneezing early in the infection. It seems likely that many events that occur during the B. bronchiseptica life cycle can be observed in this animal model. We investigated the requirement for BvgAS-mediated signal transduction during the development of infection by using B. bronchiseptica mutants that lack specific regulatory pathways within the BvgAS regulon. Our results indicate that the full colonization potential of B. bronchiseptica can only be attained when, in addition to producing factors that mediate host-microbe interactions, the bacterium is also capable of negatively regulating factors that inhibit development of the infection.
Identification of the Control Point at Which BvgAS Represses Motility
Analysis of BvgAS-regulated genes identified a control mechanism for the phenotype of motility in B. bronchiseptica. These studies revealed a transcriptional cascade whose organization, component genes, and flagellar phenotype exhibited similarity to that of E. coil (Figure 1) . The gene encoding the major structural component of the flagellar filament in B. bronchiseptica, flaA, complements mutations in the E. coli flagellin gene, fliC. DNA sequence analysis and functional complementation of E. coli flhDC mutants identified the frlAB operon as a potential analog of flhDC, which encodes an activator of flagellar gene expression (Liu and Matsumura, 1994; Komeda, 1982) . The systems differ, however, in at least one major aspect. While E. coli motility is positively controlled by a nutrient deprivation signal, B. bronchiseptica motility is repressed by the virulence control system.
The differences in regulation of motility can be attributed to differences in the promoters of master control loci in the two species. DNA sequence comparisons, mRNA analysis, and genetic data support this conclusion. Although we cannot rule out the possible existence of a BvgAS-repressed activator of frl, the frl promoter contains a strong (~70 consensus sequence near the transcriptional start site, suggesting that it should function constitutively in the absence of repression by BvgAS. Consistent with this hypothesis, ablation of the BvgAS system confers the production of motility and flagella under all conditions tested. The E. coil flhDC promoter region contains a site similar to sequences known to recruit the product of the crp gene when it is activated by the presence of cAMP, leading to transcriptional activation (Bartlett et al., 1988) . Motility and transcription of flagellar genes in E. coil require the crp locus, and mutations located in the putative promoter of the flhDC operon render E. coil motility independent of crp (Silverman and Simon, 1977) , suggesting that cAMP-CRP activates transcription from the flhDC promoter, leading to expression of the flagellar hierarchy. It is evident that frlAB fulfills a role similar to that of flhDC, since replacement of the native frl promoter with the BvgAS-activated fhaB promoter renders motility dependent on BvgAS. Therefore, BvgAS regulates the production of flagella and motility primarily at the level of frl transcription.
Colonization by B. bronchiseptica Does Not Require vrg Loci
The role of motility has been examined in a number of host-parasite interactions. In Salmonella typhimurium, the role of motility in virulence appears to be subtle (Jones et al., 1992; Schmitt et al., 1994) . However, in studies of Vibrio fischeri, Graf et al. (1994) have demonstrated a requirement for motility in colonization of host light organs. In S. typhimurium, motility is estimated to require at least 50 genes found in 13 separate operons (Macnab, 1992) and requires a significant proportion of the energy of the cell. Since this complex phenotype is conserved among B. bronchiseptica strains (Akerley et al., 1992) , it seems likely that it is required for survival of the bacterium. The role of motility in the interaction of B. bronchiseptica with the host was directly tested with mutants (RBA2 and RBA6) in which the frlAB locus was deleted. These mutants were completely defective in the production of flagella and motility. They showed no defect, however, in colonization or persistence in the rat model. These results are consistent with the observation that the bvgS-C3 mutant, in which the expression of vrg loci cannot be detected, also shows no defect in the rat model (Figure 6 ). Therefore, we have conclusively demonstrated that genes subject to negative control by BvgAS are not required for colonization of the rat respiratory tract by B. bronchiseptica.
This outcome was unexpected, as a vrg mutant (vrg-6) obtained by transposon mutagenesis of B. pertussis confers reduced bacterial persistence in a mouse model . Two possibilities could account for this difference. One possibility is that the BvgAS systems of the two species may respond to environments that select for different traits in the Bvg-phase. Some support for this hypothesis can be drawn from the observation that B. bronchiseptica does not express vrg-6 and B. pertussis is nonmotile, indicating that the Bvg-phases of the two organisms are quite different, in contrast with the extensive similarities between their BvgAS-activated genes. Alternatively, the mouse model may exert artificial selection for certain phenotypes, since the mouse is not a natural host of B. pertussis.
It is possible that some defects in the long-term survival strategy of a bacterium could produce only subtle changes in either colonization profiles or bacterial localization. The expression of vrg loci may still occur during infection despite the lack of a detectable colonization defect. To investigate this possibility, the host antibody response was used to detect in vivo expression of flagellin. If the BvgASmediated phase transition occurs during growth within a host, then the immune system of the host should detect antigens specific to both phases. No antibodies to flagella were detected during infection with wild-type B. bronchiseptica.
It has been proposed that the Bvg-phase is relatively nonimmunogenic and that down-regulation of BvgASactivated genes represents a means by which Bordetella may avoid destruction by the immune response (Lacey, 1960) . Lack of an antibody response to Bvg-phase-specific factors may result from either a lack of expression of vrg loci or the lack of immunogenicity of vrg-encoded proteins. We addressed this question in B. bronchiseptica by using the frl' mutant, infection by the frl ~ mutant, which expresses flagella ectopically during the Bvg + phase, resulted in a strong antibody response to flagella. This result indicates that flagella are immunogenic when expressed during colonization. Although it remains possible that expression of flagella in the wild-type strain may occur in an immunologically sequestered niche or stage of infection, the absence of a response to flagella during wild-type infections suggests that motility is not normally induced within the host.
The precise role of vrg loci during a natural infection has yet to be demonstrated. One possibility is that the Bvg-phase occurs during transmission between hosts, followed by a rapid transition to the Bvg ÷ phase upon encountering a new host. Consistent with this hypothesis, recent data indicates that Bvg-phase B. bronchiseptica have a survival advantage under nutrient-limiting conditions as compared with Bvg ÷ phase cultures (Cotter and Miller, 1994) . Such conditions may exist in the environment encountered by bacteria in transit between mammalian hosts. To test this hypothesis, our current experiments focus on the development of a model to observe transmission of B. bronchiseptica between animals.
Negative Regulation by BvgAS Is Required during Colonization
The observation that virulence control loci mediate pleiotropic gene activation and repression suggests that these systems respond to signals within the host. Notably, the phoP/phoQ system in S. typhimurium both activates and represses genes implicated in pathogenesis (Behlau and Miller, 1993) . Our data suggest that a BvgAS-mediated biphasic switch in gene expression patterns is not required during colonization. If this conclusion is true, then what is the importance of BvgAS-mediated regulation? This question was addressed by reversing the control of motility by BvgAS. The frl' mutant (REVl) produces flagella under conditions that activate BvgAS, leading to negative control of motility in the wild-type strain. This mutation resulted in reduced persistence in the tracheas of infected rats. Nonmotile derivatives of REVl arose during infection but were not detected in vitro. Since no defect was observed in the AfrlAB strain or in the Afrl r strain, reduced persistence of the frl r strain can be attributed to expression of frl in the Bvg ÷ phase. Restoration of persistence in the frl~AflaA strain implicates ectopic flagellar synthesis in the attenuation of virulence in the frl" mutant. This result precludes the possibility that a frl-dependent locus distinct from those involved in motility is required for the defect. Immunoblots indicate that the frr mutation does not alter the overall expression pattern or antibody response to the Bvg ÷ phase-specific antigens ( Figure 5 ). The defect in persistence may result from the introduction of a novel immunogenic target, such as the flagellum, on the cell surface. Alternatively, motility may disrupt the ability of toxins and adhesins to function at their relevant sites of action. While the precise mechanism of attenuation is currently unknown, the defective interaction of the frl ~ mutant with the host demonstrates the essential nature of negative control by BvgAS during pathogenesis. The importance of repressing factors that inhibit virulence seems to rival that of activating factors that are required for virulence.
Experimental Procedures

B. bronchiseptica Strains
Wild-type B. bronchiseptica strain RB50 was isolated in our laboratory from a naturally infected rabbit (Cotter and Miller, 1994) . Wild-type B. bronchiseptica strain GP1SN was isolated from an infected guinea pig (Akerley et al., 1992) . DM106 and RB53 contain mutations of 1 bp in bvgS corresponding to the B. pertussis bvg-C3 allele conferring the BvgAS-constitutive phenotype in both bacterial species. DM107 contains a deletion of the entire bvgAS locus. RB54 contains an inframe deletion in bvgS. The mutations in the bvgAS loci of these strains were constructed by allelic exchange, as has been described (Akerley et al., 1992; Cotter and Miller, 1994) . Mutations in flagellar genes were constructed by using an allelic exchange system that allows selection for the introduction of unmarked mutations by the resolution of chromosomal cointegrates. Mutational junctions within genes were confirmed by DNA sequencing. Inserts containing deletions in frlAB or flaA flanked by sequence homologous to the wild-type allele were cloned into pEGBR for the construction of B. bronchiseptica strains RBA2 and RB57, respectively, pEGBR is a Pstl deletion derivative of pSSl129 (Stibitz and Yang, 1991) containing the sacBR gene cartridge from pUM24 (Reid and Collmer, 1987) and the RP4 origin of transfer, which can be mobilized from E. coli SM10 to confer ampicillin resistance, kanamycin resistance, and sucrose sensitivity. Transconjugants were grown on media containing streptomycin (40 i~g/ml) to select against E. coil donors and kanamycin (40 pg/ml) to select for B. bronchiseptica recipients, This treatment selected for integration of the plasmid, since pEGBR does not replicate autonomously in Bordetella. Excision of the integrated plasmids occurred during growth on nonselective media. Subsequent growth on Luria broth (LB)-sucrose selected for cells that had undergone the second homologous recombination event as determined by the loss of kanamycin resistance. Approximately 50% of the resulting clones exhibited loss of motility as predicted, since the exchange vector carried equal lengths of homologous sequences flanking each mutation. The genotypes of strains expressing mutant phenotypes were confirmed by Southern blot analysis of genomic DNA (data not shown). Complamentation of specific deletion mutations by the minimal open reading frames of the wild-type alleles carried on mobilizable plasmid pRK290 (tetracycline-resistant) confirmed that the genomic mutations conferred the observed motility defects.
To create the frf strain, REVl, fhaB promoter sequences were amplified by polymerase chain reaction (PCR) from pDM31 containing the B. bronchieeptica fhaB promoter. This fragment contained a potential BvgA-binding site (5'-AGGAAATTTCCTA) at the same position as the site found in the B. pertussis promoter. The primers used (5'-GCGAC-ATGTCGGCGCACGCCTATACG and 5'-CAGACATGTGAAGTAATC-GGCAGAATC) contain Aflll sites that were used to introduce the fhaB promoter (from position -16 to position -209 relative to the predicted translational start site) into the Ncol site upstream of the frlA gene. A DNA fragment containing the altered frl promoter was then cloned into pEGBR for allelic exchange (as described above) in RB50 and RB54.
The position of the fhaB promoter was confirmed by sequence analysis. The genomic mutations were confirmed by Southern blot analysis (data not shown). RB54 frl' was nonmotile, while RB50 frl' was motile only under Bvg ÷ conditions. All B. bronchiseptica strains were maintained as frozen stocks at -70°C or grown on Bordet-Gengou (BG) agar containing 7.5% defibrinated sheep blood at 37°C, which permits the observation of hemolysis.
Experimental Animals
Wistar rats were obtained at 3-4 weeks of age from Charles River Laboratories (Wilmington, MA). Several animals from each lot were euthanized by halothane inhalation upon arrival and determined to be free of B. bronchiseptica infection upon necropsy (see below). Rats were briefly anesthetized with aeroeolized halothane and inoculated intranasally with 10 p.I of B. bronchiseptica in sterile PBS (phosphatebuffered saline). Inocula were grown at 37°C in Stainer-Scholte media and normalized by optical density at 600 nm. The number of CFU delivered was determined by plating dilutions on BG plates. Rats were monitored daily for signs of respiratory distress. Sneezing was observed at approximately day 3 through day 7 postinoculation in infected rats but not in uninfected rats, At the designated timepoints, postinoculation rats were euthanized by halothane inhalation, and serum samples were obtained by cardiac puncture. Lungs were added to 3 ml of PBS in a sterile plastic bag (Tekmar, Cincinnati, OH) and homogenized manually by rolling a cylinder across the bag, extruding the tissue in a fine suspension. Tracheas were ground with a Teflon homogenizer in microfuge tubes containing 200 p.I of ice-cold PBS. Dilutions of homogenized tissues were plated on BG agar and cultured at 37°C for 2 days for determination of CFU. Deep nasal swabs were obtained by first removing the distal naris and then swabbing the nasal turbinates with a calcium alginate swab. Nasal swabs were plated on BG agar with or without cephalothin, which prevents growth of the normal flora but does not affect B. bronchieeptica. B. bronchiseptica was the predominant isolate from rats infected with this bacterium, while rats free of B. bronchieeptica were colonized with a diverse array of normal flora. Mock-infected rats housed in cages adjacent to rats inoculated with B. bronohiseptica did not become infected with B. bronchiseptioa. Experiments with rabbits were performed as described previously (Cotter and Miller, 1994) .
Molecular Biology
Manipulations of nucleic acids were performed according to standard protocols (Sambrook et al., 1989) . DNA sequence analysis was conducted using Sequenase version 2.0 (US Biochemical Corporation, Cleveland, OH) essentially by the method of Sanger et al. (1977) . Sequences were analyzed with the University of Wisconsin sequence analysis software (Devereux et al., 1984) . Bacterial RNA was isolated from cultures growing exponentially in Stainer-Scholte media (Stainer and Scholte, 1971 ) and subjected to primer extension analysis as previously described (Akerley and Miller, 1993) .
Electron Microscopy
Bordetella cells grown on BG agar with or without modulators that inhibit BvgAS activity were resuspended in PBS and transferred to Formvar-coated nickel grids. Immunoelectron microscopy was performed as described previously (Harlow and Lane, 1988) , with rat sera diluted 1:20 as the primary antibody and colloidal gold-labeled goat anti-rat IgG diluted 1:20 as the secondary antibody. Grids were examined in an electron microscope (JEOL 100CX) at 80 kV of accelerating voltage.
Western Immunoblotting
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed by the method of Laemmli (1970) , using denaturing 4%-12% linear gradient gels. Proteins were transferred to Immobilon P membranes (Millipore) and reacted with rat serum at dilutions of 1:2000. Rat antibody was detected with a goat anti-rat antibody conjugated to horseradish peroxidaee at a dilution of 1:3000 by use of an enhanced chemiluminescence technique (Amersham). Flagellin was detected on immunoblots by a mouse monoclonal antibody described by Feng et al. (1990) used at a dilution of 1:2000. Antigen-antibody complexes were then detected with a goat antimouse horseradish peroxidase-conjugated antibody (at 1:2000) as described above.
ELISA
Antibody titers were quantitated by ELISA as previously described (Cotter and Miller, 1994; Hudson and Hay, 1989) . FHA purified from B. pertussis was obtained from Lederle-Praxis Biologicals (West Henrietta, NY). Flagellar filaments were purified from RB50 by CsCI equilibrium density gradient centrifugation as previously described (Akerley et al., 1992) .
